Research Article
Esophageal Stenting in the Setting of Malignancy
Table 1
Indications and contraindications for stent use in esophageal obstruction due to malignancy.
| | Indications | |
| | Unresectable malignant esophageal obstruction | | | Extrinsic esophageal compression by primary or secondary mediastinal tumors | | | Actual or impending fistula | | | Malignant gastroesophageal anastomotic leaks | | | Tumor recurrence after surgery or chemoradiotherapy | | | Contraindication to chemoradiotherapy | |
| | Contraindications | |
| | Curable disease by multimodality treatment (relative) | | | Tumor or stricture within 2 cm of proximal esophageal sphincter | | | Uncorrectable coagulopathy | | | Potential for significant airway compression | | | Recent high-dose chemoradiotherapy (within 3–6 weeks) | | | Terminal ill patient with limited life expectancy | |
|
|
Sources: [5, 6].
|
